POLE GENE MUTATION

Clinical trials for POLE GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new POLE GENE MUTATION trials appear

Sign up with your email to follow new studies for POLE GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Keytruda takes on genetic weak spots in advanced tumors

Disease control Ongoing

This phase 2 trial tests whether pembrolizumab (Keytruda) can shrink or control advanced solid tumors that have certain gene mutations (BRCA1, BRCA2, POLE, POLD1). The study enrolled 21 adults with cancers that have spread or come back. Researchers measure how many patients see t…

Matched conditions: POLE GENE MUTATION

Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control

Last updated Jun 27, 2026 12:03 UTC

POLE GENE MUTATION

Get alerted when new POLE GENE MUTATION trials appear

Keytruda takes on genetic weak spots in advanced tumors